Pulmonary arterial hypertension (PAH) is a form of pulmonary hypertension (PH), one of Janssen's areas of expertise. We believe it is important to provide people with PAH, as well as their loved ones, with the right information, tools, and advice to support them in living with this disease. This is why we developed the PH Human website together with patients from all around the world.

Pulmonary arterial hypertension

PAH is a rare, progressive, and fatal lung disease in which the blood pressure in the pulmonary arteries is elevated. Narrowing of the pulmonary arteries prevents oxygen-rich blood from reaching the heart and then being pumped further through the body. This causes a variety of health problems such as rapid fatigue, unexplained shortness of breath, chest pain, dizziness, or fainting.¹ With about 500 patients living with PAH in Belgium and an estimated 60 new diagnoses per year, Janssen is committed to providing support and education to those affected by this condition.²

PH Human

Discover a wealth of information about Pulmonary Hypertension (PH) on the PH Human website. Learn all about the disease, including symptoms, risks, and diagnostic procedures. Connect with others who understand what you're going through, ask questions, and receive tips for managing your diagnosis and work. Read inspiring stories of other patients, like Kim's journey to a correct diagnosis. And, have all the information you need from the moment of diagnosis through treatment, with access to the PAH Patient Charter, created in collaboration with Belgian PH patient association, P.H. België vzw / HTAP Belgique.

More information about Janssen

Learn more about activities in the field of pulmonary arterial hypertension and about our activities in other areas of expertise. You can also learn more about Janssen's activities in Belgium and what working at Janssen is like. Follow us via social media on Twitter, Facebook and LinkedIn to stay up to date on current developments.

©Janssen-Cilag - EM-121515 - Approval date: 02-2023